Skip to content

Clinical trials

Phase 3 Agammaglobulinemia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Agammaglobulinemia Phase: Phase 3 Country / region: Canada Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20121
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring1
Grifols Therapeutics LLC1
Kedrion S.p.A.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Agammaglobulinemia3
Primary Immunodeficiency Diseases2
Burkitt Lymphoma1
Common Variable Immunodeficiency1
Hematologic Neoplasms1
Immunologic Deficiency Syndromes1
Leukemia, Lymphocytic, Chronic, B-Cell1
Multiple Myeloma1
Severe Combined Immunodeficiency1
Wiskott-Aldrich Syndrome1

Trials

Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.